Patient-Reported Outcomes from the CARTITUDE-4 Study Showed

In CARTITUDE-4, CARVYKTI® demonstrated clinically meaningful improvements in patient-reported outcomes when compared to standard of careThe as-treated population in CARTITUDE-4 demonstrated strong rates of progression-free survival and overall responseLonger-term data from CARTITUDE-2 showed deep and durable respons...

Related Keywords

United States , Italy , American , Ying Huang , Alexandra Ventura , Jessie Yeung , Roberto Mina , University Of Torino , Corporate Communications Investor Relations , Department Of Molecular Biotechnology , Clinical Development , Health Sciences , European Organisation For Research , American Society Of Hematology , Division Of Hematology , Janssen Biotech Inc , Legend Biotech Corporation , Legend Biotech , Annual Meeting , Assistant Professor , Molecular Biotechnology , European Organisation , Cancer Quality , Life Questionnaire Core , Multiple Myeloma Symptom , Impact Questionnaire , Cytokine Release Syndrome , Chief Executive Officer , Important Safety , Release Syndrome , Effector Cell Associated Neurotoxicity Syndrome , Macrophage Activation Syndrome , Risk Evaluation , Mitigation Strategy , Nerve Palsies , Janssen Biotech , Prescribing Information , Boxed Warning , Corporate Communications , Investor Relations , Public Relations ,